pharmacogenomics
Aranscia Acquires Select Assets of PGx Firm YouScript From Invitae
Diagnostics software and services company Aranscia purchased select assets of YouScript from Invitae for an undisclosed amount.
PGx-Guided Depression Treatment Could Save Canadian Province C$956M Over 20 Years, Study Suggests
Premium
A new analysis suggests the cost of setting up PGx testing in British Columbia may be quickly offset due to fewer patients with treatment-resistant depression.
There's evidence that smoking changes how the CYP1A2 gene is expressed, which could result in some smokers needing higher doses of certain drugs.
Multigene PGx Testing Improves Outcomes for Schizophrenia Patients, Randomized Study Shows
A study comparing Chinese patients who received therapy guided by genetic testing and those who got standard care showed better outcomes for those in the PGx arm.
PGx Variants Linked to Poor Plavix Response in UK South Asians Renews Calls for Expanding Testing
Premium
A recent study found 13 percent of British South Asians have CYP2C19 variants that make them poor metabolizers of Plavix and put them at risk for another cardiac event.